Showing results (231-240 of 276) with videos related to

Sort By:
Pageof 28
Evidence-Based Complementary and Alternative Medicine : Ecam|July 9, 2019
Studies on Antibacterial Activity and Diversity of Cultivable Actinobacteria Isolated from Mangrove Soil in Futian and Maoweihai of ChinaFeina Li, Shaowei Liu, Qinpei Lu, et al.
Free Radical Biology & Medicine|April 10, 2026
Echinacoside Improves Antioxidant Responses and Angiogenesis Through Parkin-MFN2-Mediated Mitophagy to Promote Diabetic Wound HealingZi Li, Zhi Li, Qiubo Li, et al.
Cancer Letters|October 22, 2020
NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphomaFei Lu, Yanan Zhao, Yihua Pang, et al.
Cancer Medicine|October 30, 2023
Comparative analysis of clinicopathologic characteristics and prognosis between nasal and nonnasal extranodal NK/T-cell lymphomaZiyuan Shen, Xicheng Chen, Cai Sun, et al.
Leukemia|October 20, 2022
METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4Mingying Li, Jingjing Ye, Yuan Xia, et al.
Functional & Integrative Genomics|May 28, 2026
Integrating ex vivo drug sensitivity and genetic mutation analysis improves prediction of chemotherapy response in acute myeloid leukemiaWěi Li, Min Ji, Wei Li, et al.
Hematological Oncology|January 21, 2023
Prognostic value of prognostic nutritional index on extranodal natural killer/T-cell lymphoma patients: A multicenter propensity score matched analysis of 1022 cases in Huaihai Lymphoma Working GroupZiyuan Shen, Shuo Zhang, Xicheng Chen, et al.
Frontiers in Cell and Developmental Biology|June 3, 2022
Deacetylation of YAP1 Promotes the Resistance to Chemo- and Targeted Therapy in FLT3-ITD+ AML CellsPanpan Feng, Jingru Zhang, Juan Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 16, 2020
TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1Yihua Pang, Yanan Zhao, Yan Wang, et al.
The Oncologist|March 16, 2026
Construction of a predictive model based on the risk of relapse after cytarabine consolidation therapy in AML patientsMin Ji, Yiping Hao, Wei Li, et al.
Pageof 28